Scott Oliver, OD
Optometrist · Rock Hill, SCNPI 1316922446
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $10,246 of the $16,297 with a category attached, or 62.9%. Coopervision Inc. accounts for 70.8% of it on its own, with 21 other manufacturers making up the rest. Reporting peaked in 2020 at $10,786 and has fallen 93.4% since, to $716 in 2025. Among optometrist clinicians in SC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 122 payments — averaging $133.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Coopervision Inc.$12K
- Johnson & Johnson Surgical Vision, Inc.$1K
- Alcon$575
- AbbVie$527
- Tarsus Pharmaceuticals, Inc.$338
- Optos, Inc.$308
- plus $2K from 16 others
What the payments were for
- Consulting fees$2502%
- Speaking & faculty fees$10,24663%
- Travel & lodging$1,1327%
- Food & beverage$4,56828%
- Entertainment$1021%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Coopervision Inc. | 18 | $11,544 |
| Johnson & Johnson Surgical Vision, Inc. | 7 | $1,401 |
| Alcon | 12 | $575 |
| AbbVie(2 entities) | 13 | $527 |
| Tarsus Pharmaceuticals, Inc. | 9 | $338 |
| Optos, Inc. | 3 | $308 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 11 | $284 |
| Bausch & Lomb Americas Inc. | 5 | $202 |
| Johnson & Johnson Vision Care, Inc. | 3 | $164 |
| Sun Pharmaceutical Industries Inc. | 18 | $162 |
| Oyster Point Pharma, Inc. | 6 | $143 |
| Astellas Pharma US Inc | 1 | $122 |
| Maculogix, Inc. | 1 | $109 |
| LKC Technologies, Inc. | 1 | $88 |
| Biotissue Holdings Inc. | 1 | $64 |
| Harrow Eye, LLC | 2 | $57 |
| Aerie Pharmaceuticals, Inc. | 2 | $43 |
| Dompe US, Inc. | 2 | $43 |
| Carl Zeiss Meditec USA, Inc. | 1 | $41 |
| Eyevance Pharmaceuticals LLC | 2 | $29 |
| Novartis | 2 | $29 |
| Shire North American Group Inc | 2 | $27 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Non-Product Brand Specific$7,370
- Clariti Contact Lens$3,447
- PANORAMIC OPHTHALMOSCOPE$411
- MyDay Contact Lens$314
- OCT OPHTHALMOSCOPE$206
- NFC-700$206
- Acuvue$152
- enVista Aspire IOL$125
- VUITY$125
- Rhopressa$124
- Rocklatan$124
- Izervay$122
- TOTAL30$117
- LUMIGAN$113
- Hydrus Microstent$112
- AdaptDx$109
- MiSight Contact Lens$103
- P200DTx$102
- P200T$102
- P200TE$102
How this compares
$16,297 in reported general payments places this provider in the 95th percentile of 653 optometrist providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RestasisCyclosporine | 25 | $37,492 |
| LumiganBimatoprost | 54 | $20,242 |
| XiidraLifitegrast | 16 | $13,219 |
| Cyclosporine | 26 | $11,048 |
| CombiganBrimonidine Tartrate/Timolol | 24 | $5,900 |
| RocklatanNetarsudil Mesylat/Latanoprost | 18 | $5,864 |
| SimbrinzaBrinzolamide/Brimonidine Tart | 16 | $4,354 |
| Alphagan PBrimonidine Tartrate | 11 | $3,682 |
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 11 | $2,563 |
| Latanoprost | 264 | $2,253 |
| Brimonidine Tartrate | 95 | $1,600 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 49 | $1,353 |
| Tobramycin-DexamethasoneTobramycin/Dexamethasone | 36 | $1,124 |
| Dorzolamide Hcl | 20 | $539 |
| Prednisolone Acetate | 16 | $452 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRestasis, Lumigan, Combigan, Alphagan P | $527 | $67,317114 claims |
| Bausch & Lomb Americas Inc.Xiidra | $202 | $13,21916 claims |
| Aerie Pharmaceuticals, Inc.Rocklatan | $43 | $5,86418 claims |
| AlconSimbrinza | $575 | $4,35416 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 653 optometrist providers in South Carolina.
Other optometrist in Rock Hill
- David OliverRock Hill$6K
- Brandi M SalazarRock Hill$5K
- Thomas WeshefskyMyrtle Beach$77K
- Richard BedellCharleston$55K
- Patrick VollmerColumbia$49K
- William ColemanEasley$22K
- Furman SmithMt Pleasant$21K
- Jennifer ZolmanCharleston$21K
- Steven AndreasenGreenville$19K
- Bridget WhaleyGreenville$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.